Search research articles
Contact Us
Filters
Showing results (131-140 of 182) with videos related to
Page
of 19
Sort By:
The International Journal of Artificial Organs
|
July 1, 1983
Plasma exchange in acute renal failure by cortinarius speciosissimus
G Busnach, A Dal Col, M L Perrino, et al.
Minerva Nefrologica
|
April 1, 1980
[Renal involvement in progressive systemic sclerosis (scleroderma). Anatomo-clinical study of 7 cases]
M Surian, A Antonacci, C Rovati, et al.
European Journal of Clinical Pharmacology
|
January 1, 1995
Effects of somatostatin and loxiglumide on gallbladder motility
R J Lieverse, J B Jansen, M C Jebbink, et al.
Gut
|
February 1, 1991
Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog
A J de Jong, M V Singer, J B Jansen, et al.
Osteoarthritis and Cartilage
|
August 8, 2007
Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
O Bruyere, K Pavelka, L C Rovati, et al.
Cancer Research
|
May 1, 1989
Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas
B R Douglas, R A Woutersen, J B Jansen, et al.
Gastroenterology
|
February 1, 1989
Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas
B R Douglas, R A Woutersen, J B Jansen, et al.
Osteoarthritis and Cartilage
|
September 19, 2019
Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial
L C Rovati, N Brambilla, T Blicharski, et al.
Annals of the Rheumatic Diseases
|
February 2, 2012
A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis
Francis Berenbaum, Joachim Grifka, Sara Cazzaniga, et al.
Clinical and Experimental Rheumatology
|
March 10, 2004
Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate
S Christgau, Y Henrotin, L B Tankó, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 182) with videos related to
Sort By:
Page
of 19
The International Journal of Artificial Organs
|
July 1, 1983
Plasma exchange in acute renal failure by cortinarius speciosissimus
G Busnach, A Dal Col, M L Perrino, et al.
Minerva Nefrologica
|
April 1, 1980
[Renal involvement in progressive systemic sclerosis (scleroderma). Anatomo-clinical study of 7 cases]
M Surian, A Antonacci, C Rovati, et al.
European Journal of Clinical Pharmacology
|
January 1, 1995
Effects of somatostatin and loxiglumide on gallbladder motility
R J Lieverse, J B Jansen, M C Jebbink, et al.
Gut
|
February 1, 1991
Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog
A J de Jong, M V Singer, J B Jansen, et al.
Osteoarthritis and Cartilage
|
August 8, 2007
Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials
O Bruyere, K Pavelka, L C Rovati, et al.
Cancer Research
|
May 1, 1989
Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas
B R Douglas, R A Woutersen, J B Jansen, et al.
Gastroenterology
|
February 1, 1989
Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas
B R Douglas, R A Woutersen, J B Jansen, et al.
Osteoarthritis and Cartilage
|
September 19, 2019
Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial
L C Rovati, N Brambilla, T Blicharski, et al.
Annals of the Rheumatic Diseases
|
February 2, 2012
A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis
Francis Berenbaum, Joachim Grifka, Sara Cazzaniga, et al.
Clinical and Experimental Rheumatology
|
March 10, 2004
Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate
S Christgau, Y Henrotin, L B Tankó, et al.
Page
of 19